供卵周期中35654枚同胞卵母细胞玻璃化冷冻的效率与有效性
该回顾性队列分析纳入1844个供卵周期(37520枚卵母细胞),比较同一刺激周期来源的同胞新鲜与玻璃化冷冻卵母细胞的生殖结局。玻璃化组受精率和胚胎形态学评分显著降低,但调整后活产率无显著差异;当考虑复苏效率(可用卵母细胞数相同)时,两组持续妊娠和活产率相当。
要点
- 玻璃化冷冻卵母细胞的受精率和胚胎形态学评分显著低于新鲜同胞卵母细胞(P<0.001)。
- 未调整及调整分析中,玻璃化组持续妊娠率32.1% vs 新鲜组37.5%(P<0.001;OR 0.88,95%CI 0.77,1.00),活产率32.1% vs 31.9%(P=0.92;OR 1.16,95%CI 0.90,1.49)。
- 当复苏后可用卵母细胞数与新鲜周期相同时,两组持续妊娠(33.5% vs 34.1%;P=0.82)和活产率(32.1% vs 32%;P=0.97)相当。
核心结论
- 玻璃化供卵的体外受精效率低于新鲜卵母细胞,但有效性仍与新鲜周期相当。
- 当复苏后可用卵母细胞数与新鲜卵母细胞数相等时,包括活产在内的生殖结局相当。
- 作者建议在临床中实施严格的玻璃化/复苏效率指标,并优化方案以最大化存活率。
研究设计与样本
- 回顾性队列分析,纳入1844个供卵周期(37520枚卵母细胞),每位供卵者同一卵巢刺激周期提供至少一个新鲜卵母细胞接受周期(2561周期)和一个玻璃化卵母细胞接受周期(2471周期)的同胞卵母细胞。
- 分析共纳入35654枚卵母细胞,所有胚胎移植(n=5032)在2011年至2017年间进行。
主要发现
- 玻璃化卵母细胞的受精率和胚胎形态学评分显著低于新鲜卵母细胞(P<0.001)。
- 未调整及调整分析中,玻璃化组持续妊娠率32.1% vs 新鲜组37.5%(P<0.001;OR 0.88,95%CI 0.77,1.00),活产率32.1% vs 31.9%(P=0.92;OR 1.16,95%CI 0.90,1.49)。
- 考虑复苏效率后,两组持续妊娠率33.5% vs 34.1%(P=0.82;OR 1.11,95%CI 0.87,1.43),活产率32.1% vs 32%(P=0.97;OR 1.15,95%CI 0.89,1.48)。
- 在可用卵母细胞数相同且玻璃化组复苏存活率100%的周期中,持续妊娠率34.8% vs 32.4%(P=0.42;OR 1.32,95%CI 0.98,1.77),活产率32.9% vs 31.0%(P=0.52;OR 1.27,95%CI 0.95,1.71)。
关键数值与推荐
- 持续妊娠:玻璃化组32.1% vs 新鲜组37.5%(P<0.001;OR 0.88,95%CI 0.77,1.00)。
- 活产:玻璃化组32.1% vs 新鲜组31.9%(P=0.92;OR 1.16,95%CI 0.90,1.49)。
- 考虑复苏效率后持续妊娠:玻璃化组33.5% vs 新鲜组34.1%(P=0.82;OR 1.11,95%CI 0.87,1.43)。
- 考虑复苏效率后活产:玻璃化组32.1% vs 新鲜组32%(P=0.97;OR 1.15,95%CI 0.89,1.48)。
- 可用卵母细胞数相同且复苏存活率100%时活产:玻璃化组32.9% vs 新鲜组31.0%(P=0.52;OR 1.27,95%CI 0.95,1.71)。
临床怎么用
- 作者建议在临床中实施严格的玻璃化/复苏效率指标。
- 作者建议优化玻璃化/复苏方案以最大化存活率。
局限性
- 所有病例均使用开放玻璃化系统,且由经验丰富的胚胎学家操作,复苏存活率持续较高。
- 将结果外推至其他开放玻璃化系统、封闭玻璃化系统或复苏存活率低于90%的体外受精单位时需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is oocyte vitrification/warming as efficient and effective as using fresh oocytes in donation cycles? SUMMARY ANSWER: IVF with vitrified donor oocytes is less efficient than using fresh oocytes, but its efficacy remains comparable to that of fresh cycles. WHAT IS KNOWN ALREADY: Oocyte vitrification is used to preserve the reproductive potential of oocytes. A small number of randomized controlled trials carried out by experienced groups have shown that this technique provides fertilization, pregnancy, implantation and ongoing pregnancy rates comparable to those of fresh oocytes. However, large registry-based analyses have consistently reported lower live birth rates (LBRs) in cycles using vitrified oocytes. It is not clear whether this decrease may be due to the effect of vitrification per se on the oocytes or to the lower efficiency of the technique, as some of the oocytes do not survive after warming. STUDY DESIGN, SIZE, DURATION: Retrospective cohort analysis of 1844 cycles of oocyte donation (37 520 oocytes), each donor in the study provided enough oocytes for at least one reception cycle with fresh oocytes (2561 cycles) and one reception cycle with vitrified oocytes (2471 cycles) from the same ovarian stimulation (sibling oocytes). Overall, 35 654 oocytes were considered in the analysis. All embryo transfers (n = 5032) were carried out between 2011 and 2017. PARTICIPANTS/MATERIALS, SETTING, METHODS: Differences in reproductive outcomes after the first embryo transfer were evaluated using Pearson's Chi-squared test and regression analysis adjusted for recipient's age, BMI, sperm origin and state, day of embryo transfer, morphological score and number of transferred embryos. We performed two additional sub-analyses, to test whether the efficiency and/or effectiveness of vitrification/warming impacts reproductive results. One analysis included paired cycles where the same number of fresh and vitrified oocytes were available for ICSI (SAME sub-analysis), while the second analysis included those cycles with a 100% survival rate post-warming (SAME100 sub-analysis). MAIN RESULTS AND THE ROLE OF CHANCE: Baseline and cycle characteristics of participants were comparable between groups. Overall, fertilization rates and embryo morphological scores were significantly lower (P < 0.001) when using vitrified oocytes; moreover, vitrified oocytes also resulted in lower reproductive outcomes than sibling fresh oocytes using both unadjusted and adjusted analyses: ongoing pregnancy (32.1% versus 37.5%; P < 0.001; OR 0.88, 95% CI 0.77, 1.00) and live birth (32.1% versus 31.9%; P = 0.92; OR 1.16, 95% CI 0.90, 1.49). However, when the efficiency of warming was taken into account, reproductive outcomes in recipients became comparable: ongoing pregnancy (33.5% versus 34.1%; P = 0.82; OR 1.11, 95% CI 0.87, 1.43) and LBR (32.1% versus 32%; P = 0.97; OR 1.15, 95% CI 0.89, 1.48). Moreover, after selecting only cycles that, in addition to having the same number of oocytes available for ICSI, also had 100% post-warming survival rate in the vitrified group, reproductive outcomes were also comparable between fresh and vitrified oocytes: ongoing pregnancy (34.8% versus 32.4%; P = 0.42; OR 1.32, 95% CI 0.98, 1.77) and live birth (32.9% versus 31.0%; P = 0.52; OR 1.27, 95% CI 0.95, 1.71), indicating that reproductive outcomes of these cycles are affected by the efficiency of the vitrification/warming technique performed rather than the oocyte damage due to the fast cooling process to which oocytes are subjected. LIMITATIONS, REASONS FOR CAUTION: An open vitrification system was used for all cases, and oocyte vitrification/warming was performed by experienced embryologists with consistently high survival rates; caution must be exerted when extrapolating our results to data obtained using other open vitrification systems, closed vitrification systems or to IVF units with survival rates <90%. WIDER IMPLICATIONS OF THE FINDINGS: This is the largest cohort study comparing reproductive outcomes of vitrified and fresh sibling donor oocytes to date. We found that, when the number of oocytes available after warming is equal to the number of fresh oocytes, reproductive results including live birth are comparable. Consequently, the efficiency of vitrification must be taken into account to achieve the same reproductive outcomes as with fresh oocytes. We recommend implementing strict indicators of vitrification/warming efficiency in clinics and refining vitrification/warming protocols to maximize survival. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by intramural funding of Clínica EUGIN and by the Secretary for Universities and Research of the Ministry of Economy and Knowledge of the Government of Catalonia (GENCAT 2015 DI 048). The authors declare no conflicts of interest. TRIAL REGISTRATION NUMBER: N/A.
引用
- Cornet-Bartolomé D, Rodriguez A, García D, et al. Efficiency and efficacy of vitrification in 35 654 sibling oocytes from donation cycles. Hum Reprod. 2020. PMID: 32856058. doi:10.1093/humrep/deaa178
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。